The persistent low interest rate environment over the past few years has prompted changes in the life insurance industry. Against this backdrop, Allianz Suisse Lebensversicherungs-Gesellschaft and the reinsurance company Resolution Re have agreed on an
Tags :Lenz & Staehelin
Climeworks announced the launch of “Orca”, the world’s largest climate-positive carbon dioxide direct air capture (DAC) and storage plant in Hellisheidi, Iceland. The first of its kind plant will remove carbon dioxide from the
The Swiss Federal Administrative Court has mostly upheld a decision of the Swiss Competition Commission against Swisscom in connection with a WAN network of the Swiss Post. Swisscom has decided to appeal this decision to
On Holding, a Swiss-based athletic shoe and performance sportswear company, has completed its initial public offering (IPO) on the NYSE, consisting of an offering of 31,100,000 Class A ordinary shares, of which 25,442,391 were offered by On
Allreal has agreed to acquire 20 yield-producing properties with a total value of around CHF 500 million and 4 investment properties under construction with a total value of around CHF 210 million from Immosynergies Holding and its owner Olivier
Lenz & Staehelin’s dispute resolution team, comprised partner Harold Frey (pictured) and associate Severin Christen, have successfully represented Bank Julius Baer & Co. in appeal proceedings before the Swiss Federal Supreme Court. The appeal
Lenz & Staehelin advised global investment firm KKR and the heirs of Patrick Winter on a share sale and placement of approximately 8.6 million shares in SoftwareOne Holding, the provider of end-to-end software and cloud technology
Invesco Physical Markets Public Limited Company listed a new physical gold exchange-traded product (ETP) on SIX Swiss Exchange, on 27th August, 2021. Lenz & Staehelin assisted Invesco with all Swiss regulatory aspects for the listing
Maus Frères and Coop-Group cooperative announced the sale of all shares of Jumbo-Markt, a Swiss do-it-yourself store operator, for an undisclosed consideration. Following merger control clearance by the Swiss Competition Commission the transaction has
WuXi STA, a subsidiary of WuXi AppTec, a pharmaceutical development and manufacturing capability and technology platform company, whose shares are listed on the Shanghai Stock Exchange and the Hong Kong Stock Exchange, completed the acquisition
